Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
005690.KS Stock Summary
Top 10 Correlated ETFs
005690.KS
In the News
005690.KS Financial details
Company Rating
Buy
Market Cap
622.24B
Income
12.91B
Revenue
60.05B
Book val./share
1383.54
Cash/share
477.38
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
06 Feb 2023
P/E
48.95
Forward P/E
-
PEG
3.32
P/S
10.52
P/B
7.66
P/C
22.2
P/FCF
-27.33
Quick Ratio
1.14
Current Ratio
2.67
Debt / Equity
0
LT Debt / Equity
0
-
-
EPS (TTM)
215.2
EPS next Y
-
EPS next Q
-
EPS this Y
82.41%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
15.1%
Revenue Q/Q
27.13%
EPS Q/Q
75.68%
-
-
-
-
SMA20
-5.37%
SMA50
0.45%
SMA100
-14.82%
Inst Own
-
Inst Trans
-
ROA
11%
ROE
17%
ROC
0.1%
Gross Margin
42%
Oper. Margin
15%
Profit Margin
21%
Payout
-
Shs Outstand
60M
Shs Float
39.8M
-
-
-
-
Target Price
-
52W Range
8570.0-16450.0
52W High
-35.56%
52W Low
+23.69%
RSI
51.29
Rel Volume
0.38
Avg Volume
450.05K
Volume
172.66K
Perf Week
3.92%
Perf Month
-7.83%
Perf Quarter
-22.34%
Perf Half Y
-9.01%
-
-
-
-
Beta
-0.811703
-
-
Volatility
137.81%, 472.42%
Prev Close
-0.93%
Price
10600
Change
-1.4%
005690.KS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2021-12-31
Metric | History | 2017-12-31 | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 |
---|---|---|---|---|---|---|
Revenue per share | 431.52 | 477.57 | 541.85 | 629.77 | 848.99 | |
Net income per share | -671.27 | -213.6 | 72.52 | 87.44 | 158.7 | |
Operating cash flow per share | -34.38 | 57.36 | -1.26 | 149.77 | -87.12 | |
Free cash flow per share | -107.56 | -21.43 | -28.99 | 137.38 | -159.18 | |
Cash per share | 228.69 | 347.89 | 313.59 | 432.89 | 604.61 | |
Book value per share | 958.92 | 799.94 | 859.43 | 952.61 | 1.09K | |
Tangible book value per share | 578.29 | 686.57 | 741.71 | 847.43 | 986.17 | |
Share holders equity per share | 958.92 | 799.94 | 859.43 | 952.61 | 1.09K | |
Interest debt per share | 6.78 | 51.49 | 53.07 | 52.56 | 315.8 | |
Market cap | 376.63B | 1021.11B | 481.97B | 863.22B | 611.45B | |
Enterprise value | 364.01B | 1005.52B | 468.34B | 845.35B | 602.49B | |
P/E ratio | -9.61 | -80.52 | 110.87 | 164.68 | 64.27 | |
Price to sales ratio | 14.95 | 36.02 | 14.84 | 22.87 | 12.01 | |
POCF ratio | -187.63 | 299.89 | -6.38K | 96.15 | -117.09 | |
PFCF ratio | -59.97 | -802.51 | -277.35 | 104.82 | -64.08 | |
P/B Ratio | 6.73 | 21.5 | 9.36 | 15.12 | 9.36 | |
PTB ratio | 6.73 | 21.5 | 9.36 | 15.12 | 9.36 | |
EV to sales | 14.45 | 35.47 | 14.42 | 22.39 | 11.84 | |
Enterprise value over EBITDA | -10.15 | -91.4 | 108.01 | 119.13 | 46.59 | |
EV to operating cash flow | -181.34 | 295.31 | -6.2K | 94.16 | -115.37 | |
EV to free cash flow | -57.96 | -790.26 | -269.51 | 102.65 | -63.14 | |
Earnings yield | -0.1 | -0.01 | 0.01 | 0.01 | 0.02 | |
Free cash flow yield | -0.02 | 0 | 0 | 0.01 | -0.02 | |
Debt to equity | 0.01 | 0.06 | 0 | 0 | 0 | |
Debt to assets | 0.12 | 0.2 | 0.19 | 0.18 | 0.32 | |
Net debt to EBITDA | 0.35 | 1.42 | -3.14 | -2.52 | -0.69 | |
Current ratio | 10.86 | 9.79 | 6.27 | 6.6 | 2.67 | |
Interest coverage | 0 | 4.58 | 19.38 | 85.21 | 4.52 | |
Income quality | 0.05 | -0.27 | -0.02 | 1.71 | -0.55 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | |
Research and developement to revenue | 0.14 | 0.16 | 0.15 | 0.11 | 0.14 | |
Intangibles to total assets | 0.35 | 0.11 | 0.11 | 0.09 | 0.07 | |
Capex to operating cash flow | 2.13 | -1.37 | 22.02 | -0.08 | 0.83 | |
Capex to revenue | -0.17 | -0.16 | -0.05 | -0.02 | -0.08 | |
Capex to depreciation | -1.28 | -2.88 | -0.93 | -0.42 | -2.49 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 3.81K | 1.96K | 1.18K | 1.37K | 1.97K | |
ROIC | -0.07 | 0 | 0.03 | 0.11 | 0.11 | |
Return on tangible assets | -0.94 | -0.24 | 0.08 | 0.08 | 0.11 | |
Graham Net | 142.4 | 197.31 | 186.25 | 274.92 | 237.34 | |
Working capital | 23.47B | 29.21B | 29.13B | 36.43B | 41.58B | |
Tangible asset value | 33.77B | 40.76B | 44.46B | 50.8B | 59.12B | |
Net current asset value | 18.09B | 20.91B | 22.91B | 30.3B | 36.06B | |
Invested capital | 0.01 | 0.06 | 0.06 | 0.05 | 0.26 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 1.35B | 1.52B | 1.29B | 1.97B | 1.4B | |
Average inventory | 5.89B | 5.86B | 7.28B | 6.34B | 11.61B | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 15.32 | 23.47 | 11.26 | 36.04 | 11.14 | |
Days of inventory on hand | 115.91 | 118.57 | 154.37 | 115.83 | 224.7 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 23.83 | 15.55 | 32.41 | 10.13 | 32.75 | |
Inventory turnover | 3.15 | 3.08 | 2.36 | 3.15 | 1.62 | |
ROE | -0.7 | -0.27 | 0.08 | 0.09 | 0.15 | |
Capex per share | -73.18 | -78.79 | -27.73 | -12.39 | -72.07 |
Quarterly Fundamentals Overview
Last date of statement is 2022-09-30 for Q3
Metric | History | 2021-09-30 | 2021-12-31 | 2022-03-31 | 2022-06-30 | 2022-09-30 |
---|---|---|---|---|---|---|
Revenue per share | 219.78 | 196.8 | 289.74 | 224.85 | 289.5 | |
Net income per share | 59.64 | 31.2 | 82 | 37 | 65 | |
Operating cash flow per share | 60.35 | -188.59 | 77.67 | -4.6 | 56.29 | |
Free cash flow per share | 48.07 | -207.62 | 29.84 | -79.7 | -128.45 | |
Cash per share | 815.79 | 604.61 | 636.18 | 586.72 | 477.38 | |
Book value per share | 1.08K | 1.09K | 1.24K | 1.3K | 1.38K | |
Tangible book value per share | 952.78 | 986.17 | 1.14K | 1.2K | 1.28K | |
Share holders equity per share | 1.08K | 1.09K | 1.24K | 1.3K | 1.38K | |
Interest debt per share | 287.52 | 300.38 | 313.13 | 294.85 | 316.93 | |
Market cap | 890.2B | 782.3B | 682.37B | 694.27B | 614B | |
Enterprise value | 867.79B | 773.33B | 672.24B | 692.05B | 619.67B | |
P/E ratio | 62.24 | 104.57 | 34.6 | 77.7 | 39.62 | |
Price to sales ratio | 67.57 | 66.31 | 39.17 | 51.14 | 35.58 | |
POCF ratio | 246.07 | -69.2 | 146.13 | -2.5K | 182.98 | |
PFCF ratio | 308.95 | -62.86 | 380.38 | -144.3 | -80.19 | |
P/B Ratio | 13.75 | 11.97 | 9.14 | 8.83 | 7.44 | |
PTB ratio | 13.75 | 11.97 | 9.14 | 8.83 | 7.44 | |
EV to sales | 65.87 | 65.55 | 38.59 | 50.98 | 35.91 | |
Enterprise value over EBITDA | 183.14 | 242.33 | 106.37 | 474.58 | 168.44 | |
EV to operating cash flow | 239.88 | -68.41 | 143.96 | -2.49K | 184.66 | |
EV to free cash flow | 301.18 | -62.13 | 374.73 | -143.83 | -80.93 | |
Earnings yield | 0 | 0 | 0.01 | 0 | 0.01 | |
Free cash flow yield | 0 | -0.02 | 0 | -0.01 | -0.01 | |
Debt to equity | 0 | 0 | 0 | 0 | 0 | |
Debt to assets | 0.34 | 0.32 | 0.28 | 0.27 | 0.27 | |
Net debt to EBITDA | -4.73 | -2.81 | -1.6 | -1.52 | 1.54 | |
Current ratio | 2.58 | 2.67 | 3.07 | 3.07 | 2.67 | |
Interest coverage | 4.47 | -0.77 | 6.61 | -1.77 | -3.71 | |
Income quality | 1.01 | -6.04 | 0.95 | -0.12 | 0.87 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.01 | 0.01 | 0.01 | 0.02 | 0.03 | |
Research and developement to revenue | 0.09 | 0.3 | 0.09 | 0.13 | 0.08 | |
Intangibles to total assets | 0.08 | 0.07 | 0.06 | 0.06 | 0.05 | |
Capex to operating cash flow | -0.2 | 0.1 | -0.62 | 16.32 | -3.28 | |
Capex to revenue | -0.06 | -0.1 | -0.17 | -0.33 | -0.64 | |
Capex to depreciation | -1.83 | -2.03 | -4.45 | -21.2 | -18.04 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 1.2K | 874.79 | 1.51K | 1.04K | 1.42K | |
ROIC | 0.05 | -0.01 | 0.06 | 0.02 | 0.03 | |
Return on tangible assets | 0.04 | 0.02 | 0.05 | 0.02 | 0.04 | |
Graham Net | 346.36 | 237.34 | 282.98 | 236.78 | 103.38 | |
Working capital | 42.42B | 41.58B | 48.36B | 48.07B | 41.59B | |
Tangible asset value | 57.12B | 59.12B | 68.47B | 72.39B | 76.29B | |
Net current asset value | 36.23B | 36.06B | 42.77B | 42.31B | 35.69B | |
Invested capital | 0.25 | 0.26 | 0.24 | 0.24 | 0.24 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 2B | 1.58B | 2.11B | 2.33B | 2.8B | |
Average inventory | 12.82B | 16.32B | 15.54B | 15.74B | 16.35B | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 21.98 | 12.14 | 18.53 | 25.86 | 26.38 | |
Days of inventory on hand | 130.84 | 244.79 | 149.54 | 174.87 | 136.51 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 4.1 | 7.41 | 4.86 | 3.48 | 3.41 | |
Inventory turnover | 0.69 | 0.37 | 0.6 | 0.51 | 0.66 | |
ROE | 0.06 | 0.03 | 0.07 | 0.03 | 0.05 | |
Capex per share | -12.28 | -19.03 | -47.83 | -75.1 | -184.74 |
005690.KS Frequently Asked Questions
What is Pharmicell Co., Ltd. stock symbol ?
Pharmicell Co., Ltd. is a KR stock and trading under the symbol 005690.KS
What is Pharmicell Co., Ltd. stock quote today ?
Pharmicell Co., Ltd. stock price is $10600 today.
Is Pharmicell Co., Ltd. stock public?
Yes, Pharmicell Co., Ltd. is a publicly traded company.